Ontology highlight
ABSTRACT: Objective
To investigate the incidence and potential risk factors for development of fenofibrate-associated nephrotoxicity in gout patients.Methods
A total of 983 gout patients on fenofibrate treatment who visited the dedicated Gout Clinic at the Affiliated Hospital of Qingdao University between September 2016 and June 2020 were retrospectively enrolled from the electronic records system. Fenofibrate-associated nephrotoxicity was defined as an increase in serum creatinine (SCr) ≥0.3 mg/dl within 6 months of fenofibrate initiation. The change trend of SCr and uric acid levels during the treatment period were assessed by a generalised additive mixed model (GAMM). Multivariate analysis was performed for risk factors affecting elevated SCr.Results
A total of 100 (10.2%)
SUBMITTER: Li X
PROVIDER: S-EPMC8566261 | biostudies-literature | 2021 Nov
REPOSITORIES: biostudies-literature